Therefore Hsp90 has become an attractive therapeutic target in cancer treatment, since its inhibition can induce the degradation of clients and promoting enhanced host natural killer cell-mediated tumor killing [41,45,46,47]. The gene discussed is HSP90AA1; the disease is cancer.